IT
Intellia Therapeutics Inc
🇩🇪XSTU.38IGermanyHealthcare
€9.96EURup +0.12 (+1.22%)ClosedEnd of day9:21 PM
Price€9.96+0.12 (+1.22%)
Profile
- Healthcare
- Biotechnology
- Germany
Identity
- Exchange
- Stuttgart Stock Exchange . XSTU
- Type
- Stock
- ISIN
- US45826J1051
- CUSIP
- Not reported
Company
- Employees
- 377
- Headquarters
- Cambridge, United States
- Website
- https://www.intelliatx.com
- CEO
- Dr. John M. Leonard M.D.
Market
- Shares outstanding
- 0
- Market cap
- Not reported
Highlights
- Market cap
- Not reported
- EPS LTM
- Not reported
- P/E LTM
- Not reported
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $59.51M+12.58%up year on year
- Net income
- -$399.98M+16.71%up year on year
- Gross margin
- -46.48%+90.32%up year on year
- Free cash flow
- -$466.11M-10.5%down year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.